News & Events
COVID-19 data sharing: Collaborating to bridge the data gap in Latin America
Researchers are addressing the gaps in information about the impact of COVID-19 on people with MS in…
How £513,000 is supporting 21 MS organisations through the pandemic
Six months into the COVID-19 Response Initiative
MSIF puts a spotlight on the ethical use of off-label disease modifying therapies for MS
New publication from MSIF on ethical use of off-label DMTs receives global endorsement
The MSIF movement shapes the WHO’s global action plan for epilepsy and other neurological disorders
MSIF highlights priority actions for MS in the draft global plan
Tawasol – August 2021 issue
The latest news from MS organisations in the Arab region
May 50K wins the day!
Time for a victory lap, The May 50K fundraisers have raised £1.25 million this year!
Answering questions on progressive MS treatment and research
Watch the International Progressive MS Alliance webcast
EME in Spain welcomed as MSIF’s newest member
Esclerosis Múltiple España is now an associate member of the MS International Federation
Not long until World Brain Day – find out what it’s all about
22 July – join the conversation this World Brain Day
FDA backs further research into ‘neurofilament light chain’
The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the…
Professor Alan Thompson wins the prestigious MS Charcot Award
Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of…
Alliance funds 19 Research Challenge Awards looking for answers on progression
In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in…